It was a big year for US biotechs raising cash from VCs, with flush investors sinking a record-breaking $10.5 billion into new and growing companies during 2017.
SUBSCRIBE
Biohealth Innovation
Founding Member of
Biohealth Innovation
It was a big year for US biotechs raising cash from VCs, with flush investors sinking a record-breaking $10.5 billion into new and growing companies during 2017.